Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
National Institute on Alcohol Abuse and Alcoholism (NIAAA) |
---|---|
Information provided by: | National Institute on Alcohol Abuse and Alcoholism (NIAAA) |
ClinicalTrials.gov Identifier: | NCT00006203 |
This 5-week study will examine the effects of naltrexone on alcohol craving, drinking rates, and reaction to drinking-related triggers, or cues, in participants' everyday environment and in laboratory sessions. Participants will monitor and record their daily desires to drink, environmental circumstances in which urges occur, and drinking behavior using a palm top computer. Participants will receive naltrexone or a placebo. One week after receiving medication, all participants will be asked to respond to alcohol-related cues that may or may not arouse the desire to drink.
Condition | Intervention | Phase |
---|---|---|
Alcoholism |
Drug: naltrexone (Revia) |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Placebo Control, Efficacy Study |
Official Title: | Naltrexone, Craving, and Drinking: Ecological Assessment |
Ages Eligible for Study: | 21 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | NIAAAMON0785011A1 |
Study First Received: | September 11, 2000 |
Last Updated: | October 20, 2006 |
ClinicalTrials.gov Identifier: | NCT00006203 |
Health Authority: | United States: Federal Government |
Mental Disorders Naltrexone Alcoholism |
Substance-Related Disorders Disorders of Environmental Origin Alcohol-Related Disorders |
Sensory System Agents Therapeutic Uses Physiological Effects of Drugs Narcotic Antagonists |
Peripheral Nervous System Agents Central Nervous System Agents Pharmacologic Actions |